
Sign up to save your podcasts
Or


Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.
By Dr. Neil Love4.4
7272 ratings
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.

327 Listeners

40 Listeners

67 Listeners

31 Listeners

16 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

59 Listeners

1,146 Listeners

49 Listeners

2 Listeners

363 Listeners

53 Listeners

60 Listeners

51 Listeners

196 Listeners

45 Listeners

30 Listeners

0 Listeners